ZB-R-55 - CAS 2416593-55-8

ZB-R-55 is an orally available and highly potent bimodal RIPK1 inhibitor with excellent kinase selectivity in lps-induced sepsis models for the study of SIRS and sepsis.

RIP kinase

NF-κB, Apoptosis

2416593-55-8

0.9826

C25H23N5O3

441.48

CN1C=2C(OC[C@H](NC(=O)C=3NC(CC4=CC=CC=C4)=NN3)C1=O)=CC=C(C#CC5CC5)C2

-20°C

Ice Packs

Small Compound